The 6:1 diet for the reduction of risk of breast cancer.

  • Research type

    Research Study

  • Full title

    Testing the feasibility of a 6:1 intermittent diet breast cancer risk reduction programme to promote healthy eating and prevent weight gain in women at increased risk of breast cancer.

  • IRAS ID

    343256

  • Contact name

    Michelle Harvie

  • Contact email

    MICHELLE.HARVIE@MANCHESTER.AC.UK

  • Sponsor organisation

    Manchester University NHS Foundation Trust

  • ISRCTN Number

    ISRCTN14330469

  • Duration of Study in the UK

    0 years, 11 months, 31 days

  • Research summary

    Weight gain in young women increases risk of breast cancer and other cancers and conditions. Weight gain occurs in young women attending high risk clinics and there is an unmet need for effective weight gain prevention interventions for these women. This 4 months feasibility study will test whether a novel intermittent 6:1 intermittent diet is acceptable and can promote healthy eating and limit weight gain with minimal harms in women at increased risk of breast cancer aged 18-40 who are a healthy weight. Findings will inform whether further research with the 6:1 diet is warranted
    The study will invite 30 women at increased risk of breast cancer to join the programme for 4 months. The study will see if the programme is manageable and acceptable by looking at numbers who join the programme, and the numbers who stay in the programme and how well they many manage to follow the diet. We will also ask women their views of being in the programme and trying to follow the diet with a feedback questionnaire.
    We will also look at whether the programme has any benefits for weight healthy eating, or being more active or if it has the potential to harms by increasing binge eating behaviour or impacting on sleep. Also how assess how easy the programme is to deliver and the amount of dietitian time it requires to deliver.
    Good uptake (>15%), retention to the programme (>70%) and diet adherence (>50% of potential low calorie days) and minimal harms (<10% of subjects) will mean we will conduct further research of the benefits of this diet programme.

  • REC name

    South Central - Berkshire B Research Ethics Committee

  • REC reference

    24/SC/0321

  • Date of REC Opinion

    15 Oct 2024

  • REC opinion

    Favourable Opinion